Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Abcam plc ABCM NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • GB • USD

SharesGrow Score
47/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Abcam plc (ABCM) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 1 Buy, 4 Hold.

ABCM Analyst Ratings

Hold
5
Ratings
1 Buy
4 Hold
Based on 5 analysts giving stock ratings to Abcam plc in the past 3 months
Rating breakdown
Buy
1 20%
Hold
4 80%
20%
Buy
1 analysts
80%
Hold
4 analysts
0%
Sell
0 analysts

People Also View

OPT
OPT
Opthea Limited
$3.41
+1.49%
 ANAB
ANAB
AnaptysBio, Inc.
$70.22
+2.17%
 MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
 RZLT
RZLT
Rezolute, Inc.
$3.56
-1.36%
 ADAG
ADAG
Adagene Inc.
$3.81
-0.78%
 ANTX
ANTX
AN2 Therapeutics, Inc.
$2.98
-1.00%
 AVTE
AVTE
Aerovate Therapeutics, Inc.
$2.68
+0.00%
 ACRV
ACRV
Acrivon Therapeutics, Inc. Common Stock
$1.64
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message